North Amer Frac Sand Stock Price, News & Analysis
Company Description
North Amer Frac Sand (OTC Link: NAFS) is a publicly traded packaged foods company in the Consumer Defensive sector. The company has a market capitalization of $216.5K.
NAFS stock has declined 33.3% over the past year. Shares last traded at $0.0001.
On a trailing twelve-month basis, North Amer Frac Sand reported net income of -$243K.
This page provides a comprehensive overview of NAFS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
North Amer Frac Sand (NAFS) stock last traded at $0.0001. Over the past 12 months, the stock has lost 33.3%. At a market capitalization of $216.5K, NAFS is classified as a micro-cap stock with approximately 2.2B shares outstanding.
Latest News
North Amer Frac Sand has 6 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 4 with negative movement. Key topics include management, earnings. View all NAFS news →
SEC Filings
Financial Highlights
net income was -$243K. The company generated $105K in operating cash flow.
Upcoming Events
Short Interest History
Short interest in North Amer Frac Sand (NAFS) currently stands at 101.1 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for North Amer Frac Sand (NAFS) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 7.0 days.
NAFS Company Profile & Sector Positioning
North Amer Frac Sand (NAFS) operates in the Packaged Foods industry within the broader Consumer Defensive sector and is listed on the OTC Link.
Investors comparing NAFS often look at related companies in the same sector, including Aretto Wellness (RRSFF), Plantfuel Life Inc (PLFLF), Bioadaptives (BDPT), Netbrands Corp (NBND), and Nuvim (NUVM). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NAFS's relative position within its industry.